Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2025-02-12 11:42 am Purchase | 2024-12-31 | 13G | Ultragenyx Pharmaceutical Inc. RARE | SANDS CAPITAL MANAGEMENT LLC | 4,298,003 4.700% | 179,995![]() (+4.37%) | Filing History |
2025-02-10 10:25 am Sale | 2024-12-31 | 13G | Ultragenyx Pharmaceutical Inc. RARE | Wellington Management Group LLP | 2,457,543 2.700% | -1,957,486![]() (-44.34%) | Filing History |
2024-11-14 06:42 am Sale | 2024-09-30 | 13G | Ultragenyx Pharmaceutical Inc. RARE | RTW INVESTMENTS LP | 1,968,002 2.100% | -4,919,084![]() (-71.42%) | Filing History |
2024-02-14 10:03 am Sale | 2023-12-31 | 13G | Ultragenyx Pharmaceutical Inc. RARE | T. Rowe Price Associates, Inc. | 3,453,460 4.200% | -642,928![]() (-15.69%) | Filing History |
2024-02-14 07:46 am Purchase | 2023-12-31 | 13G | Ultragenyx Pharmaceutical Inc. RARE | RTW INVESTMENTS LP | 6,887,086 8.400% | 2,920,171![]() (+73.61%) | Filing History |
2024-02-13 5:16 pm Purchase | 2023-12-29 | 13G | Ultragenyx Pharmaceutical Inc. RARE | The Vanguard Group | 8,673,432 10.560% | 1,436,909![]() (+19.86%) | Filing History |
2024-02-13 3:41 pm Purchase | 2023-12-31 | 13G | Ultragenyx Pharmaceutical Inc. RARE | SANDS CAPITAL MANAGEMENT LLC | 4,118,008 5.000% | 4,118,008![]() (New Position) | Filing History |
2024-02-08 10:18 am Sale | 2023-12-29 | 13G | Ultragenyx Pharmaceutical Inc. RARE | Wellington Management Group LLP | 4,415,029 5.380% | -787,655![]() (-15.14%) | Filing History |
2024-01-29 3:26 pm Purchase | 2023-12-31 | 13G | Ultragenyx Pharmaceutical Inc. RARE | BlackRock Inc. BLK | 5,238,400 6.400% | 901,908![]() (+20.80%) | Filing History |
2023-09-11 1:33 pm Purchase | 2023-08-31 | 13G | Ultragenyx Pharmaceutical Inc. RARE | The Vanguard Group | 7,236,523 10.120% | 862,293![]() (+13.53%) | Filing History |
2023-02-14 12:38 pm Sale | 2022-12-31 | 13G | Ultragenyx Pharmaceutical Inc. RARE | T. Rowe Price Associates, Inc. | 4,096,388 5.800% | -1,579,610![]() (-27.83%) | Filing History |
2023-02-14 10:10 am Purchase | 2022-12-31 | 13G | Ultragenyx Pharmaceutical Inc. RARE | RTW INVESTMENTS LP | 3,966,915 5.700% | 3,966,915![]() (New Position) | Filing History |
2023-02-09 11:35 am Purchase | 2022-12-30 | 13G | Ultragenyx Pharmaceutical Inc. RARE | The Vanguard Group | 6,374,230 9.090% | 453,662![]() (+7.66%) | Filing History |
2023-02-06 2:58 pm Purchase | 2022-12-30 | 13G | Ultragenyx Pharmaceutical Inc. RARE | Wellington Management Group LLP | 5,202,684 7.420% | 3,918,574![]() (+305.16%) | Filing History |
2023-02-03 12:10 pm Purchase | 2022-12-31 | 13G | Ultragenyx Pharmaceutical Inc. RARE | BlackRock Inc. BLK | 4,336,492 6.200% | 925,078![]() (+27.12%) | Filing History |
2023-01-10 08:47 am Sale | 2022-12-31 | 13G | Ultragenyx Pharmaceutical Inc. RARE | FEDERATED HERMES INC. FHI | 3,094,500 4.410% | -892,370![]() (-22.38%) | Filing History |
2022-12-09 2:31 pm Sale | 2022-12-12 | 13G | Ultragenyx Pharmaceutical Inc. RARE | Capital International Investors | 1,711,517 2.400% | -3,917,936![]() (-69.60%) | Filing History |
2022-08-10 2:56 pm Sale | 2022-07-31 | 13G | Ultragenyx Pharmaceutical Inc. RARE | T. Rowe Price Associates, Inc. | 5,675,998 8.100% | -5,849,091![]() (-50.75%) | Filing History |
2022-03-09 5:18 pm Sale | 2022-02-28 | 13G | Ultragenyx Pharmaceutical Inc. RARE | BlackRock Inc. BLK | 3,411,414 4.900% | -73,238![]() (-2.10%) | Filing History |
2022-02-14 3:02 pm Sale | 2021-12-31 | 13G | Ultragenyx Pharmaceutical Inc. RARE | FEDERATED HERMES INC. FHI | 3,986,870 5.850% | -293,658![]() (-6.86%) | Filing History |